top of page

Press Release – January 24, 2024

Ceres Nanosciences Launches New Product for Cell-Free DNA Capture and Concentration  

MANASSAS, Virginia – January 24, 2024 – Today at the Precision Medicine World Congress, Ceres Nanosciences (Ceres) announced the launch of a new product, the Nanotrap® Extraction Advanced Technology (NEAT) Liquid Biopsy Kit.

The NEAT Liquid Biopsy Kit uses the Nanotrap hydrogel particle technology to capture and concentrate cell-free DNA from plasma samples while simultaneously reducing genomic DNA contamination. The result is purer and more concentrated cell-free DNA that can be used in downstream analyses.

“The unique hydrogel nature of the Nanotrap particles enables size exclusion of larger, unwanted genomic DNA fragments and affinity capture and concentration of the more clinically relevant cell-free DNA fragments at the same time,” said Ben Lepene, Chief Technology Officer at Ceres Nanosciences. “We developed a simple and easy-to-use cell-free DNA extraction kit based on this novel approach and are very excited to see our customers use it to help improve outcomes for patients.”

The NEAT Liquid Biopsy Kit is compatible with multiple types of blood collection tubes. With automated and manual methods for plasma volumes from 1 mL to 4 mL, it can be seamlessly integrated into laboratory workflows.

“The amount of circulating tumor DNA in fluids like blood is frequently present at very low concentrations in patient samples,” said Robbie Barbero, Ph.D., Chief Business Officer at Ceres Nanosciences. “We’re seeing, on average, at least 2-fold improvements in cfDNA concentration from plasma samples as compared to other cfDNA extraction kits, which will improve the detection of those low-abundance, actionable mutations.”


Ceres is presenting performance data on the NEAT Liquid Biopsy Kit at the Precision Medicine World Congress this month and at the Advances in Genome Biology and Technology General Meeting next month. Additional information, including application notes and technical notes, are available at

# # #

About Ceres Nanosciences, Inc.
Ceres Nanosciences is a privately held company, located in Prince William County, Virginia, focused on incorporating its novel Nanotrap® Particle technology into a range of diagnostic and research products and workflows. The Nanotrap Particle technology can improve diagnostic testing by capturing, concentrating, and preserving low-abundance analytes from biological samples. Nanotrap Particle technology was developed with support from the National Institutes of Health, the Defense Advanced Research Projects Agency, the Bill and Melinda Gates Foundation, Schmidt Futures, the Defense Threat Reduction Agency, and the Virginia Catalyst Program. Learn more, including how Ceres is partnering with leading life science, biopharmaceutical, and diagnostic companies, at

Press Contact:

Ross M. Dunlap

Ceres Nanosciences, Inc

1.800.615.0418 ext. 202


bottom of page